Be among the first to experience a breakthrough that’s redefining AI-driven biomanufacturing – where real-time sensing meets fully autonomous control.
We’re preparing to launch a next-generation, AI-powered multi-channel metabolite biosensor system designed to finally close the gap between traditional, slow, hands-on bioprocess monitoring and the coming era of seamless in-line analytics and self-calibrating, closed-loop automation.
Powered by ultra-miniaturized, biocompatible smart sensor arrays tracking 20+ critical variables live, this platform unlocks capabilities bioprocess teams have long been waiting for:
- FDA PAT-ready analytics
- Instant deviation detection
- Instant deviation detection
- Dynamic optimization of feed, pH, and temperature
- Predictive insight into batch tipping points – before they happen
The impact is transformative: fewer batch failures, stronger QC, faster development cycles, and dramatically more cost-efficient biomanufacturing.
If your organization is looking to reduce deviations, boost reproducibility, or shrink development timelines from months to days, our Early Access Program offers exclusive hands-on use of technology engineered for continuous manufacturing, ESG-positive efficiency, and seamless vendor-agnostic integration.
We’re now inviting select companies and institutions to join us in early data generation and system evaluation – supported by secure edge-to-cloud data infrastructure and predictive maintenance.
Submit your Expression of Interest here: